Terms: = Kidney tumors AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Diagnosis
4 results:
1. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression.
Anderson WJ; Tsai HK; Sholl LM; Hirsch MS
Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731
[No Abstract] [Full Text] [Related]
2. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
3. Secondary tumors of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a 10-year experience.
Waters L; Si Q; Caraway N; Mody D; Staerkel G; Sneige N
Diagn Cytopathol; 2014 Sep; 42(9):738-43. PubMed ID: 24554612
[TBL] [Abstract] [Full Text] [Related]
4. Infrequent alteration of the dpc4 tumor suppressor gene in renal cell carcinoma.
Popović Hadzija M; Hrasćan R; Bosnar MH; Zeljko Z; Hadzija M; Cadez J; Pavelić K; Kapitanović S
Urol Res; 2004 Jun; 32(3):229-35. PubMed ID: 15107966
[TBL] [Abstract] [Full Text] [Related]
